Dr Xiaoxiao Wang
Xiaoxiao Wang, PhD, DABT, DCST, is a certified toxicologist and Study Director at WuXi AppTec with extensive expertise in GLP and non-GLP toxicology studies. She earned her PhD in Pharmacology from Shenyang Pharmaceutical University and has held leadership roles in preclinical development across the biopharmaceutical industry. Wang specialises in toxicology study management, molecular biology techniques and safety evaluation. She has authored multiple peer-reviewed publications in neuropharmacology and inflammation biology.
Contact info
- Article
Understanding the toxicology endpoints that matter in ADC development
Antibody-drug conjugates (ADCs) present unique toxicology challenges. Learn which endpoints matter most, how they inform development decisions and why they are essential for building a robust nonclinical safety strategy.